Alzheimer's Disease Translational Center for Disease Model Resources (U54)

Post Date

July 29th 2015

Application Due Date

January 11th 2016

Funding Opportunity Number

RFA-AG-16-014

CFDA Number(s)

93.866

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health

Number of Awards

1

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Funding

• Estimated Total Funding:

  $5000000

• Award Range:

  $None - $3500000

Grant Description

This Funding Opportunity Announcement (FOA) invites U54 Cooperative Agreement applications aiming to establish an Alzheimers Disease Translational Center for Disease Model Resources. The purpose of the Center is to: develop the next generation of rodent animal models of AD; conduct extensive characterization and clinico-pathological staging of AD animal models using translatable biomarkers; develop translatable pharmacodynamicbiomarkers for well validated therapeutic targets; develop and implement guidelines for standardized best practicesfor the rigorous preclinical testingof AD candidates; conduct preclinical testingof candidate AD therapeutics and transparent reporting.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-16-014.html